Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Vishal Chandra and Doris Benbrook.
Vishal Chandra
Connection Strength
1.572
Doris Benbrook
  1. Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer. Cancers (Basel). 2021 May 12; 13(10).
    View in: PubMed
    Score: 0.767
  2. Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors. Biomed Pharmacother. 2023 May; 161:114422.
    View in: PubMed
    Score: 0.217
  3. Distinct mechanism of cervical cancer cell death caused by the investigational new drug SHetA2. Front Oncol. 2022; 12:958536.
    View in: PubMed
    Score: 0.211
  4. Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. Invest New Drugs. 2018 08; 36(4):561-570.
    View in: PubMed
    Score: 0.152
  5. Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol. 2016 Jan; 27(1):e8.
    View in: PubMed
    Score: 0.131
  6. Pharmacodynamics of Cyclin D1 Degradation in Ovarian Cancer Xenografts with Repeated Oral SHetA2 Dosing. AAPS J. 2023 Dec 12; 26(1):5.
    View in: PubMed
    Score: 0.057
  7. Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia. J Pharm Sci. 2018 02; 107(2):638-646.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.